MOLECULAR TEMPLATES
Molecular Templates is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer. The company has a lead compound for melanoma that is expected to enter into clinical trials in the next two years and is developing additional compounds against a variety of other cancers.
MOLECULAR TEMPLATES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2000-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.mtem.com
Total Employee:
11+
Status:
Active
Contact:
5122332709
Email Addresses:
[email protected]
Total Funding:
298.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache Microsoft Exchange Online
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-02 | Threshold Pharmaceuticals | Threshold Pharmaceuticals acquired by Molecular Templates | N/A |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Debt - Molecular Templates
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Molecular Templates
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - Molecular Templates
Longitude Capital
Longitude Capital investment in Post-IPO Equity - Molecular Templates
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Molecular Templates
CAM Capital
CAM Capital investment in Post-IPO Equity - Molecular Templates
Takeda
Takeda investment in Post-IPO Equity - Molecular Templates
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Molecular Templates
Sante Ventures
Sante Ventures investment in Series D - Molecular Templates
Aju IB Investment
Aju IB Investment investment in Series C - Molecular Templates
Official Site Inspections
http://www.mtem.com Semrush global rank: 2.39 M Semrush visits lastest month: 7.69 K
- Host name: 72-48-154-166.static.grandenetworks.net
- IP address: 72.48.154.166
- Location: Austin United States
- Latitude: 30.2304
- Longitude: -97.7243
- Metro Code: 635
- Timezone: America/Chicago
- Postal: 78741
More informations about "Molecular Templates" on Search Engine
Management Team :: Molecular Templates, Inc. (MTEM)
The Molecular Templates’ management team has a track record of success in biotechnology and pharmaceuticals.See details»
Molecular Templates - Org chart | The Org
Explore Molecular Templates' organizational chart. Discover current team members including executives, board members, and advisors.See details»
Molecular Templates | LinkedIn
Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. site. https://www.mtem.com/ Industry. Biotechnology Research. Company size. 11-50 employees....See details»
Molecular Templates, Inc. Announces Fast Track Designation
AUSTIN, Texas, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced that the U.S. Food and …See details»
Molecular Templates - Crunchbase Company Profile
Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases. It primarily develops a pipeline of therapies through its proprietary biologic-engineered toxin body (ETB) drug platform with unique mechanisms of action which are highly differentiated from antibody-drug.See details»
Molecular Templates Company Profile - Craft
May 10, 2024 Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer and other serious diseases. It develops a pipeline of therapies through its proprietary biologic-engineered toxin body (ETB) drug platform. Type. Public. Status. Active. …See details»
Molecular Templates, Inc. (MTEM) Company Profile
May 17, 2024 Overview. Financials. Statistics. Forecast. Profile. Chart. Company Description. Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States.See details»
Molecular Templates Announces Up to $40 Million Private …
AUSTIN, Texas, July 13, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the...See details»
Molecular Templates, BMS partner for cancer therapies …
Feb 12, 2021 Molecular Templates (MTEM) has entered a collaboration with Bristol Myers Squibb (BMS) to discover and develop multiple novel therapies. February 12, 2021. The therapies will be designed for specific oncology targets. …See details»
Molecular Templates - Funding, Financials, Valuation & Investors
Molecular Templates. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Stock Symbol NASDAQ:MTEM. Funding Rounds 17. Total Funding Amount. Unlock for free. Lead Investors 6. Investors 14. Funding. Molecular Templates has raised a total of. $397.7M. in funding over 17 rounds.See details»
Molecular Templates | Biotech Careers
Molecular Templates (MTEM) is a clinical stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary Engineered Toxin Body (ETB) platform. MTEM’s first immunotoxin, MT-3724, is in clinical development for non-Hodgkin’s lymphoma.See details»
Molecular Templates - Contacts, Employees, Board Members, …
Organization. Molecular Templates. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 5. Number of Board Member and Advisor Profiles 1. Contacts 194. About. Molecular Templates has 5 current employee profiles, including Chief Executive Officer and Chief Scientific Officer …See details»
mtem-10k_20221231.htm - SEC.gov
Dec 31, 2022 Molecular Templates, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer. Molecular utilizes its proprietary biologic drug platform to design and generate ETBs, which Molecular believes provide a differentiated mechanism of action that may be ...See details»
Molecular Templates - Org Chart, Teams, Culture & Jobs - The Org
View Molecular Templates' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Shamelle Silver - Sr. Director, Human Resources at Molecular …
Shamelle Silver has over 20 years of work experience in human resources. Currently, they are the Director of Human Resources at Molecular Templates, where they develop and implements policies, processes, training, and initiatives to support the organization's HR compliance and strategy needs.See details»
Molecular Self-Organization | SpringerLink
Jan 1, 2015 Molecular self-organization is the process in which molecules spontaneously organized in defined structures without external direction. It is possible that a molecule intramolecularly self-organizes like proteins; however, “molecular organization” is commonly used to refer intermolecular organization.See details»
[2405.13469] Machine Learning for Exoplanet Detection in
May 22, 2024 The new generation of observatories and instruments (VLT/ERIS, JWST, ELT) motivate the development of robust methods to detect and characterise faint and close-in exoplanets. Molecular mapping and cross-correlation for spectroscopy use molecular templates to isolate a planet's spectrum from its host star. However, reliance on signal …See details»
IJMS | Free Full-Text | Unlocking New Avenues: Solid-State
May 18, 2024 Molecularly imprinted polymers (MIPs) are established artificial molecular recognition platforms with tailored selectivity towards a target molecule, whose synthesis and functionality are highly influenced by the nature of the solvent employed in their synthesis. Steps towards the “greenification” of molecular imprinting technology (MIT) …See details»
Eric Poma - Chief Executive Officer and Chief Scientific Officer ...
Eric Poma. Summary. Overview. CB Rank (Person) 68,571. Primary Job Title Chief Executive Officer and Chief Scientific Officer. Primary Organization. Molecular Templates. Location Georgetown, Texas, United States. Regions Southern US. Gender Male.See details»
Expanding the versatility of trihalophenols as molecular templates …
May 20, 2024 A series of [2 + 2] cycloaddition reactions involving trans-1,2-bis(2-pyridyl)ethylene that is templated by three 2,4,6-trihalophenols is reported. In each case, the co-crystal undergoes a quantitative and stereoselective photoreaction to generate the corresponding cyclobutane, namely rctt-tetrakis(2-pyridylSee details»